Shots: Parvus to receive an upfront & milestones exceeding $800M and royalties on sales of products targeting for IBD, ALD & Celiac diseases, and will conduct pre/clinical studies till P-I […]readmore
Tags : Agreement
Shots: Iconic to receive $7.5M upfront, funds for preclinical development and is eligible for option exercise payment, development, regulatory & commercial milestones, royalties on sales. Exelixis to get an option […]readmore
Shots: Kymera to receive $70M upfront including equity investment, >$1B as development, regulatory & commercial milestones for up to 6 therapies opted by Vertex, royalties on sales of products and […]readmore
Shots: Progenics to receive royalties on sales of 1404 in EU. ROTOP to get an exclusive license to develop & commercialize 1404 in EU and is also responsible for regulatory […]readmore
Shots: Onconova to receive e $6M upfront including $2M cash, $2M shares & $2M as escrow funding with $45.5M regulatory, development & commercial milestones and royalties on sales. HanX to […]readmore
Shots: Takeda enters into a licensing agreement with Curadev for its Stimulator of Interferon Genes (STING) agonist/ CRD5500 and its associated patents The focus of the agreement is to develop […]readmore
Shots: Purdue to receive one-time payment from Eisai, while releasing itself from rights to develop & commercialize lemborexant. Eisai acquires WW development and commercialization rights for lemborexant, previously held by […]readmore
Shots: EirGenix to receive upfront, milestones with profit sharing on sales and will be responsible for the development & manufacturing of proposed biosimilar trastuzumab. Sandoz to get WW rights to […]readmore
Shots: GSK to receive shares of Fulcrum’s preferred stock, milestones & royalties on sales of losmapimod. Fulcrum to get exclusive WW rights to develop & commercialize of losmapimod with all […]readmore
Shots: The Perelman School of Medicine at the University of Pennsylvania & Sensus Healthcare enter into a research & development agreement for Sculptura robotic IORT system In Feb’19, Sculptura has […]readmore